论文信息 - Pharmacotherapy during neonatal extracorporeal membrane oxygenation: toward an evidence-based approach - 字舞流文

Pharmacotherapy during neonatal extracorporeal membrane oxygenation: toward an evidence-based approach

K. Allegaert | M. Rayyan

[1] D. Tibboel,et al. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation , 2006, Critical care.

[2] D. Tibboel,et al. Morphine Metabolite Pharmacokinetics during Venoarterial Extra Corporeal Membrane Oxygenation in Neonates , 2006, Clinical pharmacokinetics.

[3] N. Holford,et al. Population clinical pharmacology of children: general principles , 2006, European Journal of Pediatrics.

[4] N. Holford,et al. Population clinical pharmacology of children: modelling covariate effects , 2006, European Journal of Pediatrics.

[5] D. Elbourne,et al. Cost-Effectiveness of Neonatal Extracorporeal Membrane Oxygenation Based on 7-Year Results From the United Kingdom Collaborative ECMO Trial , 2006, Pediatrics.

[6] C. Robertson,et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. , 2006, Acta paediatrica.

[7] H. Mulla,et al. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. , 2005, British journal of clinical pharmacology.

[8] Graham Lawson,et al. Pharmacokinetics of Midazolam in Neonates Undergoing Extracorporeal Membrane Oxygenation , 2003, Anesthesiology.